Estrogen Receptor-positive Breast Cancer Clinical Trials in Chicago, Illinois
2 recruitingChicago, Illinois
Showing 1–2 of 2 trials
Recruiting
Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Breast NeoplasmsHER2-negative Breast CancerInvasive Breast Cancer+1 more
Atossa Therapeutics, Inc.87 enrolled15 locationsNCT05607004
Recruiting
Phase 2
Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer
Metastatic Breast CancerEstrogen Receptor-positive Breast CancerHER2/Neu-Negative Breast Cancer+1 more
Northwestern University174 enrolled1 locationNCT06062498